Tech Company Financing Transactions
Buzzkill Labs Funding Round
Buzzkill Labs closed a Series A funding round on 5/17/2023. Backers included Poseidon Asset Management and private investors.
Transaction Overview
Company Name
Announced On
5/17/2023
Transaction Type
Amount
Unknown
Round
Series A
Investors
Poseidon Asset Management (Lead Investor)
private investors (Lead Investor)
Proceeds Purpose
The company intends to use the funds to commercialize its technology, which fills employers' critical need to maintain safe workplaces while respecting the dignity of employees who legally use cannabis outside of work.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
7683 Southfront Rd #250
Livermore, CA 94551
US
Livermore, CA 94551
US
Phone
Undisclosed
Website
Email Address
Overview
Buzzkill Labs is modernizing drug testing for a world of legal cannabis. We are developing and commercializing portable, rapid, cost-effective testing of oral fluid (saliva) that distinguishes and measures THC parent compound, the psychoactive component of cannabis that causes impairment. Our technology helps to eliminate cheating and to determine current potential impairment versus past use with no interference from CBD or metabolites in 15 minutes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Heimburge
Chief Technical Officer
George Farquar
Browse more venture capital transactions:
Prev: 5/17/2023: Immunefi venture capital transaction
Next: 5/17/2023: Gradiant venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs